TB-500 for UAE laboratories

Wolverine is BPC-157 5 mg plus TB-500 5 mg under one 10 mg total and one lot. A protocol written against this standalone 5 mg vial and executed with Wolverine is also receiving 5 mg of a second sequence. That is an identity change, not a packaging change. The TB-500 and Wolverine comparison sets the documentation boundary.

GLOW and KLOW add further components. None of those records can release a vial labelled TB-500 5mg. Order this SKU when the certificate must describe the fragment alone. Order a blend only when the combination is the object of the work.

BPC-157 10mg is the other single-sequence line most often written onto the same requisition. The fills differ (5 mg versus 10 mg) and the sequences differ. Strength alone will not catch a swap if someone abbreviated both names on a rack label. Print the full catalogue name.

Diluent is not included. With 5 mg in the vial there is little room for a second attempt — fix concentration and volume in the written procedure before opening. The reconstitution basics guide covers the record-keeping side.

Match the printed lot in batch verification or the TB-500 COA index. Confirm standalone TB-500, the 5 mg fill and the lot. A Wolverine, GLOW, KLOW or BPC-157 certificate must not be filed against this unit. Unpublished lots wait on a documentation request.

Store sealed vials at 2–8 °C, protected from light and moisture. Dispatch covers the seven emirates with AED checkout. Log the lot and receipt time and move the parcel into cold storage before the paperwork is finished.

Cell-migration and actin-binding papers describe model systems. They do not describe this manufacturing lot. VaultLabs makes no statements about tissue, recovery or physiological effects.

TB-500 is supplied for in vitro laboratory research only — not for human or animal use, personal use or medical application — with no administration or preparation guidance for living systems.